Published in J Biol Chem on May 22, 1998
In situ atomic force microscopy study of Alzheimer's beta-amyloid peptide on different substrates: new insights into mechanism of beta-sheet formation. Proc Natl Acad Sci U S A (1999) 2.24
Trace amounts of copper in water induce beta-amyloid plaques and learning deficits in a rabbit model of Alzheimer's disease. Proc Natl Acad Sci U S A (2003) 2.02
Role of ganglioside metabolism in the pathogenesis of Alzheimer's disease--a review. J Lipid Res (2008) 1.68
Contribution by synaptic zinc to the gender-disparate plaque formation in human Swedish mutant APP transgenic mice. Proc Natl Acad Sci U S A (2002) 1.68
Aβ delays fibrin clot lysis by altering fibrin structure and attenuating plasminogen binding to fibrin. Blood (2012) 1.65
Therapeutics for Alzheimer's disease based on the metal hypothesis. Neurotherapeutics (2008) 1.58
Copper binding to octarepeat peptides of the prion protein monitored by mass spectrometry. Protein Sci (2000) 1.57
In vivo reduction of amyloid-beta by a mutant copper transporter. Proc Natl Acad Sci U S A (2003) 1.52
Structural characterization of copper(II) binding to alpha-synuclein: Insights into the bioinorganic chemistry of Parkinson's disease. Proc Natl Acad Sci U S A (2005) 1.50
Dietary Cu stabilizes brain superoxide dismutase 1 activity and reduces amyloid Abeta production in APP23 transgenic mice. Proc Natl Acad Sci U S A (2003) 1.46
Oxidative stress and the pathogenesis of Alzheimer's disease. Oxid Med Cell Longev (2013) 1.44
Copper in the brain and Alzheimer's disease. J Biol Inorg Chem (2009) 1.40
Protonation, tautomerization, and rotameric structure of histidine: a comprehensive study by magic-angle-spinning solid-state NMR. J Am Chem Soc (2011) 1.37
The Caenorhabditis elegans A beta 1-42 model of Alzheimer disease predominantly expresses A beta 3-42. J Biol Chem (2009) 1.32
Molecular-level examination of Cu2+ binding structure for amyloid fibrils of 40-residue Alzheimer's β by solid-state NMR spectroscopy. J Am Chem Soc (2011) 1.27
Trace metal contamination initiates the apparent auto-aggregation, amyloidosis, and oligomerization of Alzheimer's Abeta peptides. J Biol Inorg Chem (2004) 1.21
Metals and amyloid-beta in Alzheimer's disease. Int J Exp Pathol (2005) 1.19
A nontransgenic mouse model shows inducible amyloid-beta (Abeta) peptide deposition and elucidates the role of apolipoprotein E in the amyloid cascade. Proc Natl Acad Sci U S A (2004) 1.18
Substoichiometric levels of Cu2+ ions accelerate the kinetics of fiber formation and promote cell toxicity of amyloid-{beta} from Alzheimer disease. J Biol Chem (2010) 1.13
Copper, beta-amyloid, and Alzheimer's disease: tapping a sensitive connection. Proc Natl Acad Sci U S A (2003) 1.13
Chronic mild cerebrovascular dysfunction as a cause for Alzheimer's disease? Exp Gerontol (2010) 1.12
Redox reactions of copper complexes formed with different beta-amyloid peptides and their neuropathological [correction of neuropathalogical] relevance. Biochemistry (2007) 1.12
Role of metal dyshomeostasis in Alzheimer's disease. Metallomics (2011) 1.12
Amyloid beta ion channel: 3D structure and relevance to amyloid channel paradigm. Biochim Biophys Acta (2007) 1.11
Engineering metal ion coordination to regulate amyloid fibril assembly and toxicity. Proc Natl Acad Sci U S A (2007) 1.10
Amyloid plaques in PSAPP mice bind less metal than plaques in human Alzheimer's disease. Neuroimage (2009) 1.07
Environmental pollutants as risk factors for neurodegenerative disorders: Alzheimer and Parkinson diseases. Front Cell Neurosci (2015) 1.07
Copper(II) binding to alpha-synuclein, the Parkinson's protein. J Am Chem Soc (2008) 1.05
The galvanization of beta-amyloid in Alzheimer's disease. Proc Natl Acad Sci U S A (2002) 1.05
Increase in the conformational flexibility of beta 2-microglobulin upon copper binding: a possible role for copper in dialysis-related amyloidosis. Protein Sci (2004) 1.04
Alzheimer disease beta-amyloid activity mimics cholesterol oxidase. J Clin Invest (2005) 1.04
Zinc and copper modulate Alzheimer Abeta levels in human cerebrospinal fluid. Neurobiol Aging (2007) 1.04
Bifunctional compounds for controlling metal-mediated aggregation of the aβ42 peptide. J Am Chem Soc (2012) 1.03
Chronic copper exposure exacerbates both amyloid and tau pathology and selectively dysregulates cdk5 in a mouse model of AD. J Neurochem (2009) 1.03
Acceleration of amyloid beta-peptide aggregation by physiological concentrations of calcium. J Biol Chem (2006) 1.02
The neurotoxicity of environmental aluminum is still an issue. Neurotoxicology (2010) 1.01
Link between Aluminum and the Pathogenesis of Alzheimer's Disease: The Integration of the Aluminum and Amyloid Cascade Hypotheses. Int J Alzheimers Dis (2011) 1.01
Amyloid precursor protein and alpha synuclein translation, implications for iron and inflammation in neurodegenerative diseases. Biochim Biophys Acta (2008) 1.01
Altered microglial copper homeostasis in a mouse model of Alzheimer's disease. J Neurochem (2010) 1.01
Metal ion transporters in mammals: structure, function and pathological implications. J Physiol (1999) 0.99
Soluble aggregates of the amyloid-beta protein selectively stimulate permeability in human brain microvascular endothelial monolayers. J Neurochem (2008) 0.97
Copper transport and Alzheimer's disease. Eur Biophys J (2007) 0.96
Indoleamine 2,3-dioxygenase and 3-hydroxykynurenine modifications are found in the neuropathology of Alzheimer's disease. Redox Rep (2010) 0.96
Mitochondrial dynamics in Alzheimer's disease: opportunities for future treatment strategies. Drugs Aging (2010) 0.95
Drosophila melanogaster as a model organism for Alzheimer's disease. Mol Neurodegener (2013) 0.95
A central role for dityrosine crosslinking of Amyloid-β in Alzheimer's disease. Acta Neuropathol Commun (2013) 0.94
Cu(II) mediates kinetically distinct, non-amyloidogenic aggregation of amyloid-beta peptides. J Biol Chem (2011) 0.94
Alzheimer's disease & metals: therapeutic opportunities. Br J Pharmacol (2011) 0.93
Challenges associated with metal chelation therapy in Alzheimer's disease. J Alzheimers Dis (2009) 0.93
Paradoxical condensation of copper with elevated beta-amyloid in lipid rafts under cellular copper deficiency conditions: implications for Alzheimer disease. J Biol Chem (2009) 0.93
Presenilins promote the cellular uptake of copper and zinc and maintain copper chaperone of SOD1-dependent copper/zinc superoxide dismutase activity. J Biol Chem (2011) 0.92
Pharmacotherapeutic targets in Alzheimer's disease. J Cell Mol Med (2008) 0.91
Control of Alzheimer's amyloid beta toxicity by the high molecular weight immunophilin FKBP52 and copper homeostasis in Drosophila. PLoS One (2010) 0.91
Pulsed hydrogen-deuterium exchange mass spectrometry probes conformational changes in amyloid beta (Aβ) peptide aggregation. Proc Natl Acad Sci U S A (2013) 0.91
Iron and mechanisms of neurotoxicity. Int J Alzheimers Dis (2010) 0.91
Structural and thermodynamical properties of CuII amyloid-beta16/28 complexes associated with Alzheimer's disease. J Biol Inorg Chem (2006) 0.90
Systematic review of potential health risks posed by pharmaceutical, occupational and consumer exposures to metallic and nanoscale aluminum, aluminum oxides, aluminum hydroxide and its soluble salts. Crit Rev Toxicol (2014) 0.90
A kinetic model for beta-amyloid adsorption at the air/solution interface and its implication to the beta-amyloid aggregation process. J Phys Chem B (2009) 0.90
Metallomic profiling and linkage map analysis of early Parkinson's disease: a new insight to aluminum marker for the possible diagnosis. PLoS One (2010) 0.90
Oxidative stress in neurodegenerative diseases. Neural Regen Res (2012) 0.90
Serum albumin prevents protein aggregation and amyloid formation and retains chaperone-like activity in the presence of physiological ligands. J Biol Chem (2012) 0.90
Amyloid beta and the longest-lived rodent: the naked mole-rat as a model for natural protection from Alzheimer's disease. Neurobiol Aging (2013) 0.89
Nanoprobing of the effect of Cu(2+) cations on misfolding, interaction and aggregation of amyloid β peptide. J Neuroimmune Pharmacol (2012) 0.89
Immunization with amyloid-beta attenuates inclusion body myositis-like myopathology and motor impairment in a transgenic mouse model. J Neurosci (2009) 0.89
Crystallization and preliminary X-ray diffraction analysis of the Fab fragment of WO2, an antibody specific for the Abeta peptides associated with Alzheimer's disease. Acta Crystallogr Sect F Struct Biol Cryst Commun (2008) 0.88
Copper abolishes the beta-sheet secondary structure of preformed amyloid fibrils of amyloid-beta(42). J Alzheimers Dis (2009) 0.88
Variants of DsRed fluorescent protein: Development of a copper sensor. Protein Sci (2006) 0.87
The effect of Cu(2+) and Zn(2+) on the Aβ42 peptide aggregation and cellular toxicity. Metallomics (2013) 0.86
Genetic inhibition of solute-linked carrier 39 family transporter 1 ameliorates aβ pathology in a Drosophila model of Alzheimer's disease. PLoS Genet (2012) 0.86
Role of water-soluble amyloid-beta in the pathogenesis of Alzheimer's disease. Int J Exp Pathol (2005) 0.86
Bioluminescence imaging reveals inhibition of tumor cell proliferation by Alzheimer's amyloid beta protein. Cancer Cell Int (2009) 0.86
Mechanism of zinc(II)-promoted amyloid formation: zinc(II) binding facilitates the transition from the partially alpha-helical conformer to aggregates of amyloid beta protein(1-28). J Biol Inorg Chem (2008) 0.86
Intracellular amyloid formation in muscle cells of Abeta-transgenic Caenorhabditis elegans: determinants and physiological role in copper detoxification. Mol Neurodegener (2009) 0.86
Concepts for the treatment of Alzheimer's disease: molecular mechanisms and clinical application. Int J Exp Pathol (2005) 0.85
Metals and cholesterol: two sides of the same coin in Alzheimer's disease pathology. Front Aging Neurosci (2014) 0.85
Biometals and their therapeutic implications in Alzheimer's disease. Neurotherapeutics (2015) 0.85
Antibodies to potato virus Y bind the amyloid beta peptide: immunohistochemical and NMR studies. J Biol Chem (2008) 0.84
Early diagnostics and therapeutics for Alzheimer's disease--how early can we get there? Expert Rev Neurother (2006) 0.84
Clioquinol promotes the degradation of metal-dependent amyloid-β (Aβ) oligomers to restore endocytosis and ameliorate Aβ toxicity. Proc Natl Acad Sci U S A (2014) 0.84
Iron inhibits neurotoxicity induced by trace copper and biological reductants. J Biol Inorg Chem (2004) 0.84
Novel therapeutics for Alzheimer's disease: an update. Curr Opin Drug Discov Devel (2010) 0.84
Quantification of the binding properties of Cu2+ to the amyloid beta peptide: coordination spheres for human and rat peptides and implication on Cu2+-induced aggregation. J Phys Chem B (2010) 0.84
A synthetic peptide with the putative iron binding motif of amyloid precursor protein (APP) does not catalytically oxidize iron. PLoS One (2012) 0.84
A pH-dependent conformational transition of Abeta peptide and physicochemical properties of the conformers in the glial cell. Biochem J (2002) 0.83
PARP-1 modulates amyloid beta peptide-induced neuronal damage. PLoS One (2013) 0.83
The pathological roles of ganglioside metabolism in Alzheimer's disease: effects of gangliosides on neurogenesis. Int J Alzheimers Dis (2011) 0.83
Copper-triggered aggregation of ubiquitin. PLoS One (2009) 0.82
Issues raised involving the copper hypotheses in the causation of Alzheimer's disease. Int J Alzheimers Dis (2011) 0.82
Aggregation pathways of the amyloid β(1-42) peptide depend on its colloidal stability and ordered β-sheet stacking. Langmuir (2012) 0.82
Is Alzheimer's disease amyloidosis the result of a repair mechanism gone astray? Alzheimers Dement (2011) 0.82
Conserved rhodopsin intradiscal structural motifs mediate stabilization: effects of zinc. Biochemistry (2009) 0.81
Links between copper and cholesterol in Alzheimer's disease. Front Physiol (2013) 0.81
Molecular basis for the Cu2+ binding-induced destabilization of beta2-microglobulin revealed by molecular dynamics simulation. Biophys J (2006) 0.81
Calorimetric investigation of copper(II) binding to Aβ peptides: thermodynamics of coordination plasticity. J Biol Inorg Chem (2012) 0.81
Structural elements regulating amyloidogenesis: a cholinesterase model system. PLoS One (2008) 0.80
Spatial memory deficits in a mouse model of late-onset Alzheimer's disease are caused by zinc supplementation and correlate with amyloid-beta levels. Front Aging Neurosci (2014) 0.80
Modulation of protein kinase C by curcumin; inhibition and activation switched by calcium ions. Br J Pharmacol (2006) 0.80
Possible involvement of copper(II) in Alzheimer disease. Environ Health Perspect (2002) 0.79
Iron-chelating backbone coupled with monoamine oxidase inhibitory moiety as novel pluripotential therapeutic agents for Alzheimer's disease: a tribute to Moussa Youdim. J Neural Transm (Vienna) (2011) 0.79
Correlation of copper interaction, copper-driven aggregation, and copper-driven h(2)o(2) formation with aβ40 conformation. Int J Alzheimers Dis (2010) 0.79
A polymorphic DNA marker genetically linked to Huntington's disease. Nature (1984) 16.71
Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature (1995) 13.80
The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell (1999) 11.59
Mutation detection and single-molecule counting using isothermal rolling-circle amplification. Nat Genet (1998) 9.84
Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science (1995) 8.31
Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. Science (1987) 8.29
Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease. Ann Neurol (1999) 7.69
Alpha-2 macroglobulin is genetically associated with Alzheimer disease. Nat Genet (1998) 7.26
B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells. J Exp Med (2001) 6.97
Revealing the maximum strength in nanotwinned copper. Science (2009) 6.27
Rapid induction of Alzheimer A beta amyloid formation by zinc. Science (1994) 5.34
Exploring the DNA-binding specificities of zinc fingers with DNA microarrays. Proc Natl Acad Sci U S A (2001) 5.08
The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene. Nat Genet (1993) 4.70
Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice. Neuron (2001) 4.42
Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD. Neurology (2005) 3.90
The genetic defect causing familial Alzheimer's disease maps on chromosome 21. Science (1987) 3.59
The CBFbeta subunit is essential for CBFalpha2 (AML1) function in vivo. Cell (1996) 3.55
Quantitative interpretation of magnetization transfer. Magn Reson Med (1993) 3.55
Global analysis of gene expression in pulmonary fibrosis reveals distinct programs regulating lung inflammation and fibrosis. Proc Natl Acad Sci U S A (2000) 3.47
A prognostic score for patients with lower risk myelodysplastic syndrome. Leukemia (2007) 3.45
Dynamic disruptions in nuclear envelope architecture and integrity induced by HIV-1 Vpr. Science (2001) 3.37
TGF-beta is a critical mediator of acute lung injury. J Clin Invest (2001) 3.29
Smoking duration, intensity, and risk of Parkinson disease. Neurology (2010) 3.19
Evidence for genetic linkage of Alzheimer's disease to chromosome 10q. Science (2000) 3.16
Localization of the Huntington's disease gene to a small segment of chromosome 4 flanked by D4S10 and the telomere. Cell (1987) 3.11
'Seed' analysis of off-target siRNAs reveals an essential role of Mcl-1 in resistance to the small-molecule Bcl-2/Bcl-XL inhibitor ABT-737. Oncogene (2006) 3.10
DNA markers for nervous system diseases. Science (1984) 3.02
Studies of the lamin proteinase reveal multiple parallel biochemical pathways during apoptotic execution. Proc Natl Acad Sci U S A (1995) 2.89
Isolation of polymorphic DNA fragments from human chromosome 4. Nucleic Acids Res (1987) 2.83
Parallel genotyping of human SNPs using generic high-density oligonucleotide tag arrays. Genome Res (2000) 2.79
The fibronectin type III domain as a scaffold for novel binding proteins. J Mol Biol (1998) 2.65
Clearance of Alzheimer's Abeta peptide: the many roads to perdition. Neuron (2004) 2.65
The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction. Biochemistry (1999) 2.58
Genetics of aging. Science (1997) 2.57
Connective tissue growth factor mediates transforming growth factor beta-induced collagen synthesis: down-regulation by cAMP. FASEB J (1999) 2.50
Rapid movements of vimentin on microtubule tracks: kinesin-dependent assembly of intermediate filament networks. J Cell Biol (1998) 2.44
Alzheimer-associated presenilins 1 and 2: neuronal expression in brain and localization to intracellular membranes in mammalian cells. Nat Med (1996) 2.43
COP9 signalosome-specific phosphorylation targets p53 to degradation by the ubiquitin system. EMBO J (2001) 2.41
Disruption of nuclear lamin organization alters the distribution of replication factors and inhibits DNA synthesis. J Cell Biol (1997) 2.41
Homozygotes for Huntington's disease. Nature (1987) 2.40
Watching the growth of bulk grains during recrystallization of deformed metals. Science (2004) 2.38
LDL receptor-related protein, a multifunctional ApoE receptor, binds secreted beta-amyloid precursor protein and mediates its degradation. Cell (1995) 2.37
Uptake of HIV-1 tat protein mediated by low-density lipoprotein receptor-related protein disrupts the neuronal metabolic balance of the receptor ligands. Nat Med (2000) 2.34
Motile properties of vimentin intermediate filament networks in living cells. J Cell Biol (1998) 2.33
Cleavage of lamin A by Mch2 alpha but not CPP32: multiple interleukin 1 beta-converting enzyme-related proteases with distinct substrate recognition properties are active in apoptosis. Proc Natl Acad Sci U S A (1996) 2.31
Cu(II) potentiation of alzheimer abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction. J Biol Chem (1999) 2.30
Mapping, cloning and genetic characterization of the region containing the Wilson disease gene. Nat Genet (1993) 2.29
Clustering of multiallele DNA markers near the Huntington's disease gene. J Clin Invest (1989) 2.25
Presenilin-mediated modulation of capacitative calcium entry. Neuron (2000) 2.25
Deletion of Huntington's disease-linked G8 (D4S10) locus in Wolf-Hirschhorn syndrome. Nature (1985) 2.19
Studies of a DNA marker (G8) genetically linked to Huntington disease in British families. Hum Genet (1986) 2.18
Measles, mumps, and rubella (MMR) vaccine and autism. Ecological studies cannot answer main question. BMJ (2001) 2.15
Characterization of pp60c-src tyrosine kinase activities using a continuous assay: autoactivation of the enzyme is an intermolecular autophosphorylation process. Biochemistry (1995) 2.13
Regulation of presynaptic terminal organization by C. elegans RPM-1, a putative guanine nucleotide exchanger with a RING-H2 finger domain. Neuron (2000) 2.12
Prognostic factors for progression-free and overall survival with sunitinib targeted therapy and with cytokine as first-line therapy in patients with metastatic renal cell carcinoma. Ann Oncol (2010) 2.06
Context sequences of translation initiation codon in plants. Plant Mol Biol (1997) 2.05
Modulation of beta-amyloid precursor protein processing by the low density lipoprotein receptor-related protein (LRP). Evidence that LRP contributes to the pathogenesis of Alzheimer's disease. J Biol Chem (2000) 2.00
A general and efficient copper catalyst for the amidation of aryl halides and the N-arylation of nitrogen heterocycles. J Am Chem Soc (2001) 1.99
Acyl-coenzyme A: cholesterol acyltransferase modulates the generation of the amyloid beta-peptide. Nat Cell Biol (2001) 1.96
Leukocyte extravasation into the pancreatic tissue in transgenic mice expressing interleukin 10 in the islets of Langerhans. J Exp Med (1993) 1.94
Residue-based control of helix shape in beta-peptide oligomers. Nature (1997) 1.94
The anxiolytic effect of Bifidobacterium longum NCC3001 involves vagal pathways for gut-brain communication. Neurogastroenterol Motil (2011) 1.93
Alzheimer's disease: genetic studies and transgenic models. Annu Rev Genet (1998) 1.93
Repression of ribosome and tRNA synthesis in secretion-defective cells is signaled by a novel branch of the cell integrity pathway. Mol Cell Biol (2000) 1.88
Genetic absence of gamma-interferon delays but does not prevent diabetes in NOD mice. Diabetes (1996) 1.85
Characterization of copper interactions with alzheimer amyloid beta peptides: identification of an attomolar-affinity copper binding site on amyloid beta1-42. J Neurochem (2000) 1.82
Architecture for a Web-based clinical information system that keeps the design open and the access closed. Proc AMIA Symp (1998) 1.79
Vascular endothelial growth factor as a marker of tumor endothelium. Cancer Res (1998) 1.78
Expression of a ubiquitous, cross-reactive homologue of the mouse beta-amyloid precursor protein (APP). J Biol Chem (1994) 1.74
Inducible expression of mutant alpha-synuclein decreases proteasome activity and increases sensitivity to mitochondria-dependent apoptosis. Hum Mol Genet (2001) 1.74
Isolation and characterization of APLP2 encoding a homologue of the Alzheimer's associated amyloid beta protein precursor. Nat Genet (1993) 1.72
The amyloid protein precursor of Alzheimer's disease is a mediator of the effects of nerve growth factor on neurite outgrowth. Neuron (1992) 1.72
Huntington disease: no evidence for locus heterogeneity. Genomics (1989) 1.70
The gene defects responsible for familial Alzheimer's disease. Neurobiol Dis (1996) 1.68
Induction of type I diabetes by interferon-alpha in transgenic mice. Science (1993) 1.68
The diagnosis and treatment of dentinogenic ghost cell tumor. Int J Oral Maxillofac Surg (2009) 1.67
Alternative cleavage of Alzheimer-associated presenilins during apoptosis by a caspase-3 family protease. Science (1997) 1.66
Insights into the dynamic properties of keratin intermediate filaments in living epithelial cells. J Cell Biol (2001) 1.66
Isolation of polymorphic DNA segments from human chromosome 21. Nucleic Acids Res (1985) 1.66
Pathway of incorporation of microinjected lamin A into the nuclear envelope. J Cell Biol (1992) 1.66